# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Hemingway (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET003-SYN-TD
- Date: 1955-03-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Walter Brandt-Ochoa, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for establishing primary care: heavy drinking, low mood and forgetfulness a year after two plane crashes, with high blood pressure and abnormal liver and iron tests on the intake panel. **S**

## Objective

Hemoglobin: 15.6 g/dL; MCV: 102 fL (high); Platelets: 208 10*3/uL; Sodium: 138 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.98 mg/dL; eGFR (CKD-EPI 1950): 91 mL/min/1.73 m²; Glucose: 96 mg/dL; AST: 70 U/L (high); ALT: 78 U/L (high); GGT: 196 U/L (high); Total bilirubin: 1 mg/dL; Albumin: 4.1 g/dL; Serum iron: 214 ug/dL (high); Transferrin saturation: 76% (high); Ferritin: 1460 ng/mL (high); HbA1c: 6.1% (high); Total cholesterol: 214 mg/dL (high); LDL cholesterol: 118 mg/dL; HDL cholesterol: 52 mg/dL; Triglycerides: 236 mg/dL (high); TSH: 2.1 mIU/L; Vitamin B12: 412 pg/mL; Urine albumin-to-creatinine ratio: 14 mg/g; AUDIT: 26; PHQ-9: 16; MoCA: 25. All results are synthetic.

BP 152/94 mmHg; pulse 88 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 97% on room air; weight 98 kg; BMI 29.3 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Alcohol use disorder, severe; heavy daily drinking for most of his adult life; synthetic modern episode linked to his documented heavy drinking; Raised transferrin saturation and ferritin found on routine intake tests, cause not yet known (heavy drinking, liver disease or iron overload); Major depressive disorder, single episode, moderate; Mood Disorder Questionnaire negative and no history of mania or hypomania; Essential hypertension, stage 2, with heavy drinking contributing; Post-concussion symptoms (headaches, slowed thinking and forgetfulness) after repeated head injuries, most recently a concussion with a skull fracture a year ago; chronic traumatic encephalopathy is not diagnosed; Prediabetes (HbA1c 6.1%). Strengths and supports remain part of the care plan. **S**

## Medication changes

- Started: Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinking **S**
- Started: Thiamine 100 mg oral tablet, one tablet daily **S**
- Started: Sertraline 50 mg oral tablet, one tablet daily **S**
- Started: Amlodipine 5 mg oral tablet, one tablet daily **S**

## Plan

- Alcohol: AUDIT and DSM-5-TR assessment, brief intervention in his own terms, naltrexone 50 mg daily, thiamine, a drinking diary, a goal he chooses and revisits, withdrawal precautions if he stops (no abrupt stop at his intake level without a plan), and mutual-help or counseling options offered. Guideline: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Hepatology consultation for raised iron studies and liver tests in a heavy drinker: to confirm the cause, stage the liver, and plan treatment. Guideline: Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases (2011); ACG Clinical Guideline: Hereditary Hemochromatosis (2019) **S**
- Depression: PHQ-9 at each visit, weekly psychotherapy (cognitive behavioral therapy) with the clinic's behavioral health clinician, sertraline, the Mood Disorder Questionnaire before the antidepressant, a structured safety assessment with a written safety plan, lethal-means counseling about firearms, the 988 Suicide & Crisis Lifeline, and safety review at every visit. Guideline: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026) **S**
- Post-concussion symptoms: symptom-based care (headache plan without daily analgesics, sleep routine, graded activity, writing in shorter sessions), MoCA repeated after three months with less alcohol, no routine brain imaging without warning signs, and neuropsychological testing if thinking does not improve; chronic traumatic encephalopathy not diagnosed. Guideline: VA/DoD Clinical Practice Guideline for the Management and Rehabilitation of Post-Acute Mild Traumatic Brain Injury (2021) **S**
- Hypertension: home blood pressure monitoring, amlodipine, less alcohol and salt, ECG and urine albumin at diagnosis, echocardiogram for stage 2 hypertension, and a target below 130/80 mmHg. Guideline: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026) **S**
- Prediabetes: HbA1c repeated at six months, less alcohol, activity and diet; iron overload and alcohol both raise the risk of diabetes. Guideline: ACG Clinical Guideline: Hereditary Hemochromatosis (2019); Prediabetes and Type 2 Diabetes: Screening (2021) **S**
